GAVRETO (PRALSETINIB) — FDA Approval NDA214701 (BLUEPRINT MEDICINES)
GAVRETO (PRALSETINIB) — FDA Approval NDA214701 (BLUEPRINT MEDICINES) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: GAVRETO; Active ingredients: PRALSETINIB; Application number: NDA214701.
| Brand name | GAVRETO |
|---|---|
| Active ingredients | PRALSETINIB |
| Application number | NDA214701 |
| Sponsor | BLUEPRINT MEDICINES |
| Dosage form | CAPSULE |
| Route | ORAL |
| Marketing status | Prescription |
| Products in application | 1 |
| First approval date | 20201201 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →